Click for best price
Stem Cell Therapy for Diabetes Related Conditions Market Size, Share 2023
Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy for Diabetes and Related Conditions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy for Diabetes and Related Conditions. This report contains market size and forecasts of Stem Cell Therapy for Diabetes and Related Conditions in global, including the following market information:
Global Stem Cell Therapy for Diabetes and Related Conditions Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Stem Cell Therapy for Diabetes and Related Conditions market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
NSI-566 is the stem cell therapy candidate under development by one of the key companies Neuralstem. The molecule is being developed for the treatment of individuals with diabetic neuropathy and is currently in the pre-clinical development stage. The mechanism of action of this stem cell therapy includes cell replacement that eventually leads to neurogenesis stimulation.
We surveyed the Stem Cell Therapy for Diabetes and Related Conditions companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Stem Cell Therapy for Diabetes and Related Conditions Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Stem Cell Therapy for Diabetes and Related Conditions Market Segment Percentages, by Type, 2022 (%)
Monotherapy
Combination Therapy
Global Stem Cell Therapy for Diabetes and Related Conditions Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Stem Cell Therapy for Diabetes and Related Conditions Market Segment Percentages, by Application, 2022 (%)
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Diabetic Foot Ulcer
Diabetic Nephropathy
Diabetic Neuropathy
Global Stem Cell Therapy for Diabetes and Related Conditions Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Stem Cell Therapy for Diabetes and Related Conditions Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Stem Cell Therapy for Diabetes and Related Conditions revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Stem Cell Therapy for Diabetes and Related Conditions revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Athersys
Mesoblast
Caladrius Biosciences
Sanofi
Novo Nordisk
Outline of Major Chapters:
Chapter 1: Introduces the definition of Stem Cell Therapy for Diabetes and Related Conditions, market overview.
Chapter 2: Global Stem Cell Therapy for Diabetes and Related Conditions market size in revenue.
Chapter 3: Detailed analysis of Stem Cell Therapy for Diabetes and Related Conditions company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Stem Cell Therapy for Diabetes and Related Conditions in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Stem Cell Therapy for Diabetes and Related Conditions Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Stem Cell Therapy for Diabetes and Related Conditions Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Stem Cell Therapy for Diabetes and Related Conditions Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Stem Cell Therapy for Diabetes and Related Conditions Overall Market Size
2.1 Global Stem Cell Therapy for Diabetes and Related Conditions Market Size: 2022 VS 2029
2.2 Global Stem Cell Therapy for Diabetes and Related Conditions Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Stem Cell Therapy for Diabetes and Related Conditions Players in Global Market
3.2 Top Global Stem Cell Therapy for Diabetes and Related Conditions Companies Ranked by Revenue
3.3 Global Stem Cell Therapy for Diabetes and Related Conditions Revenue by Companies
3.4 Top 3 and Top 5 Stem Cell Therapy for Diabetes and Related Conditions Companies in Global Market, by Revenue in 2022
3.5 Global Companies Stem Cell Therapy for Diabetes and Related Conditions Product Type
3.6 Tier 1, Tier 2 and Tier 3 Stem Cell Therapy for Diabetes and Related Conditions Players in Global Market
3.6.1 List of Global Tier 1 Stem Cell Therapy for Diabetes and Related Conditions Companies
3.6.2 List of Global Tier 2 and Tier 3 Stem Cell Therapy for Diabetes and Related Conditions Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Stem Cell Therapy for Diabetes and Related Conditions Market Size Markets, 2022 & 2029
4.1.2 Monotherapy
4.1.3 Combination Therapy
4.2 By Type - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue & Forecasts
4.2.1 By Type - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue, 2018-2023
4.2.2 By Type - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue, 2024-2029
4.2.3 By Type - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2022 & 2029
5.1.2 Type 1 Diabetes Mellitus
5.1.3 Type 2 Diabetes Mellitus
5.1.4 Diabetic Foot Ulcer
5.1.5 Diabetic Nephropathy
5.1.6 Diabetic Neuropathy
5.2 By Application - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue & Forecasts
5.2.1 By Application - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue, 2018-2023
5.2.2 By Application - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue, 2024-2029
5.2.3 By Application - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2022 & 2029
6.2 By Region - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue & Forecasts
6.2.1 By Region - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue, 2018-2023
6.2.2 By Region - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue, 2024-2029
6.2.3 By Region - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Stem Cell Therapy for Diabetes and Related Conditions Revenue, 2018-2029
6.3.2 US Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.3.3 Canada Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.3.4 Mexico Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Stem Cell Therapy for Diabetes and Related Conditions Revenue, 2018-2029
6.4.2 Germany Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.4.3 France Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.4.4 U.K. Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.4.5 Italy Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.4.6 Russia Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.4.7 Nordic Countries Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.4.8 Benelux Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Stem Cell Therapy for Diabetes and Related Conditions Revenue, 2018-2029
6.5.2 China Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.5.3 Japan Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.5.4 South Korea Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.5.5 Southeast Asia Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.5.6 India Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Stem Cell Therapy for Diabetes and Related Conditions Revenue, 2018-2029
6.6.2 Brazil Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.6.3 Argentina Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Revenue, 2018-2029
6.7.2 Turkey Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.7.3 Israel Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.7.4 Saudi Arabia Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
6.7.5 UAE Stem Cell Therapy for Diabetes and Related Conditions Market Size, 2018-2029
7 Stem Cell Therapy for Diabetes and Related Conditions Companies Profiles
7.1 Athersys
7.1.1 Athersys Company Summary
7.1.2 Athersys Business Overview
7.1.3 Athersys Stem Cell Therapy for Diabetes and Related Conditions Major Product Offerings
7.1.4 Athersys Stem Cell Therapy for Diabetes and Related Conditions Revenue in Global Market (2018-2023)
7.1.5 Athersys Key News & Latest Developments
7.2 Mesoblast
7.2.1 Mesoblast Company Summary
7.2.2 Mesoblast Business Overview
7.2.3 Mesoblast Stem Cell Therapy for Diabetes and Related Conditions Major Product Offerings
7.2.4 Mesoblast Stem Cell Therapy for Diabetes and Related Conditions Revenue in Global Market (2018-2023)
7.2.5 Mesoblast Key News & Latest Developments
7.3 Caladrius Biosciences
7.3.1 Caladrius Biosciences Company Summary
7.3.2 Caladrius Biosciences Business Overview
7.3.3 Caladrius Biosciences Stem Cell Therapy for Diabetes and Related Conditions Major Product Offerings
7.3.4 Caladrius Biosciences Stem Cell Therapy for Diabetes and Related Conditions Revenue in Global Market (2018-2023)
7.3.5 Caladrius Biosciences Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Stem Cell Therapy for Diabetes and Related Conditions Major Product Offerings
7.4.4 Sanofi Stem Cell Therapy for Diabetes and Related Conditions Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Novo Nordisk
7.5.1 Novo Nordisk Company Summary
7.5.2 Novo Nordisk Business Overview
7.5.3 Novo Nordisk Stem Cell Therapy for Diabetes and Related Conditions Major Product Offerings
7.5.4 Novo Nordisk Stem Cell Therapy for Diabetes and Related Conditions Revenue in Global Market (2018-2023)
7.5.5 Novo Nordisk Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Stem Cell Therapy for Diabetes and Related Conditions Market Opportunities & Trends in Global Market
Table 2. Stem Cell Therapy for Diabetes and Related Conditions Market Drivers in Global Market
Table 3. Stem Cell Therapy for Diabetes and Related Conditions Market Restraints in Global Market
Table 4. Key Players of Stem Cell Therapy for Diabetes and Related Conditions in Global Market
Table 5. Top Stem Cell Therapy for Diabetes and Related Conditions Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Stem Cell Therapy for Diabetes and Related Conditions Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Share by Companies, 2018-2023
Table 8. Global Companies Stem Cell Therapy for Diabetes and Related Conditions Product Type
Table 9. List of Global Tier 1 Stem Cell Therapy for Diabetes and Related Conditions Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Stem Cell Therapy for Diabetes and Related Conditions Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Stem Cell Therapy for Diabetes and Related Conditions Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Stem Cell Therapy for Diabetes and Related Conditions Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Stem Cell Therapy for Diabetes and Related Conditions Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Stem Cell Therapy for Diabetes and Related Conditions Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2024-2029
Table 30. Athersys Company Summary
Table 31. Athersys Stem Cell Therapy for Diabetes and Related Conditions Product Offerings
Table 32. Athersys Stem Cell Therapy for Diabetes and Related Conditions Revenue (US$, Mn) & (2018-2023)
Table 33. Athersys Key News & Latest Developments
Table 34. Mesoblast Company Summary
Table 35. Mesoblast Stem Cell Therapy for Diabetes and Related Conditions Product Offerings
Table 36. Mesoblast Stem Cell Therapy for Diabetes and Related Conditions Revenue (US$, Mn) & (2018-2023)
Table 37. Mesoblast Key News & Latest Developments
Table 38. Caladrius Biosciences Company Summary
Table 39. Caladrius Biosciences Stem Cell Therapy for Diabetes and Related Conditions Product Offerings
Table 40. Caladrius Biosciences Stem Cell Therapy for Diabetes and Related Conditions Revenue (US$, Mn) & (2018-2023)
Table 41. Caladrius Biosciences Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Stem Cell Therapy for Diabetes and Related Conditions Product Offerings
Table 44. Sanofi Stem Cell Therapy for Diabetes and Related Conditions Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi Key News & Latest Developments
Table 46. Novo Nordisk Company Summary
Table 47. Novo Nordisk Stem Cell Therapy for Diabetes and Related Conditions Product Offerings
Table 48. Novo Nordisk Stem Cell Therapy for Diabetes and Related Conditions Revenue (US$, Mn) & (2018-2023)
Table 49. Novo Nordisk Key News & Latest Developments
List of Figures
Figure 1. Stem Cell Therapy for Diabetes and Related Conditions Segment by Type in 2022
Figure 2. Stem Cell Therapy for Diabetes and Related Conditions Segment by Application in 2022
Figure 3. Global Stem Cell Therapy for Diabetes and Related Conditions Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Stem Cell Therapy for Diabetes and Related Conditions Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Stem Cell Therapy for Diabetes and Related Conditions Revenue in 2022
Figure 8. By Type - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
Figure 9. By Application - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
Figure 10. By Type - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
Figure 12. By Application - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
Figure 14. By Region - Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
Figure 15. By Country - North America Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
Figure 16. US Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
Figure 20. Germany Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 21. France Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
Figure 28. China Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 32. India Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
Figure 34. Brazil Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share, 2018-2029
Figure 37. Turkey Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Stem Cell Therapy for Diabetes and Related Conditions Revenue, (US$, Mn), 2018-2029
Figure 41. Athersys Stem Cell Therapy for Diabetes and Related Conditions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Mesoblast Stem Cell Therapy for Diabetes and Related Conditions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Caladrius Biosciences Stem Cell Therapy for Diabetes and Related Conditions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi Stem Cell Therapy for Diabetes and Related Conditions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novo Nordisk Stem Cell Therapy for Diabetes and Related Conditions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
